HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epidural Co-Administration of Dexmedetomidine and Levobupivacaine Improves the Gastrointestinal Motility Function after Colonic Resection in Comparison to Co-Administration of Morphine and Levobupivacaine.

AbstractUNLABELLED:
Gastrointestinal motility may be impaired after intestinal surgery. Epidural morphine is effective in controlling postoperative pain, but can further reduce gastrointestinal motility. Here, we aimed to investigate the effects of epidural dexmedetomidine on gastrointestinal motility in patients undergoing colonic resection. Seventy-four patients undergoing colonic resection were enrolled in this clinical trial and allocated randomly to treatment with dexmedetomidine (D group) or morphine (M group). The D group received a loading dose epidural administration of 3 ml dexmedetomidine (0.5 μg kg(-1)) and then a continuous epidural administration of 80 μg dexmedetomidine in 150 ml levobupivacaine (0.125%) at 3 ml h(-1) for two days. The M group received a loading dose epidural administration of 3 ml morphine (0.03 mg kg(-1)) and then a continuous epidural administration of 4.5 mg morphine in 150 ml levobupivacaine at 3 ml h(-1) for two days. Verbal rating score (VRS), postoperative analgesic requirements, side effects related to analgesia, the time to postoperative first flatus (FFL) and first feces (FFE) were recorded. VRS and postoperative analgesic requirements were not significantly different between treatment groups. In contrast, the time to FFL and time to FFE were significant longer in M group in comparison to D group (P < 0.05). Moreover, patients in M group had a significantly higher incidence of nausea, vomiting, and pruritus (P < 0.05). No patients showed neurologic deficits in either group. In comparison to morphine, epidural dexmedetomidine is safe and beneficial for the recovery of gastrointestinal motility after colonic resection when used as an adjunct with levobupivacaine for postoperative pain control.
TRIAL REGISTRATION:
Chinese Clinical Trial Registry ChiCTR-TRC-14004644.
AuthorsXian-Zhang Zeng, Zhi-Fang Lu, Xiang-Qi Lv, Yue-Ping Guo, Xiao-Guang Cui
JournalPloS one (PLoS One) Vol. 11 Issue 1 Pg. e0146215 ( 2016) ISSN: 1932-6203 [Electronic] United States
PMID26751791 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Dexmedetomidine
  • Morphine
  • Levobupivacaine
  • Bupivacaine
Topics
  • Aged
  • Analgesia, Epidural (methods)
  • Bupivacaine (administration & dosage, analogs & derivatives)
  • Colon (drug effects, surgery)
  • Dexmedetomidine (administration & dosage)
  • Double-Blind Method
  • Drug Administration Schedule
  • Drug Therapy, Combination (methods)
  • Feces
  • Female
  • Flatulence
  • Gastrointestinal Motility (drug effects)
  • Humans
  • Levobupivacaine
  • Male
  • Middle Aged
  • Morphine (administration & dosage)
  • Pain Management (methods)
  • Pain, Postoperative (therapy)
  • Prospective Studies
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: